← All comparisons
Head-to-head · FAERS comparison

Venlafaxine vs Fluoxetine: side effects in FDA adverse event reports

How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

VenlafaxineFluoxetine
Drug class––
Brand names––
FAERS reports131,548126,801
Serious74%72%
Death outcome13,16112,911
Boxed warningYes WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in childrenYes SUICIDAL THOUGHTS AND BEHAVIORS • Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term

Signals both drugs share

ReactionVenlafaxineFluoxetineLabel screen (A / B)
Serotonin syndrome2,520 · PRR 24.12,364 · PRR 23.2Labeled — boxed warning / Labeled — boxed warning
Major depression745 · PRR 18.0584 · PRR 14.2Labeled (related wording) / Likely indication confounding
Hyperreflexia245 · PRR 11.9212 · PRR 10.6Labeled adverse reaction / Labeled adverse reaction
Anorgasmia158 · PRR 9.8178 · PRR 11.5Labeled adverse reaction / Labeled adverse reaction
Clonus164 · PRR 10.1163 · PRR 10.4Labeled adverse reaction / Labeled adverse reaction
Hostility154 · PRR 10.1122 · PRR 8.2Labeled adverse reaction / Labeled adverse reaction
Atrial septal defect419 · PRR 8.3412 · PRR 8.5Not in label — unassessed / Not in label — unassessed
Physical deconditioning298 · PRR 21.4292 · PRR 21.7Not in label — unassessed / Not in label — unassessed
Urinary tract disorder245 · PRR 9.1233 · PRR 9.0Not in label — unassessed / Not in label — unassessed
Amaurosis fugax222 · PRR 41.6229 · PRR 44.9Not in label — unassessed / Not in label — unassessed
Tearfulness217 · PRR 8.4228 · PRR 9.2Not in label — unassessed / Not in label — unassessed
Reversible cerebral vasoconstriction syndrome118 · PRR 10.1162 · PRR 14.8Not in label — unassessed / Not in label — unassessed
Derealisation134 · PRR 10.6107 · PRR 8.7Not in label — unassessed / Not in label — unassessed
Bezoar113 · PRR 14.2115 · PRR 15.0Not in label — unassessed / Not in label — unassessed

Labeled signals distinctive to Venlafaxine

Labeled signals distinctive to Fluoxetine

Common questions

Which has more reported side effects, Venlafaxine or Fluoxetine?

Venlafaxine has 131,548 FAERS reports and Fluoxetine 126,801. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (74% vs 72%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Venlafaxine and Fluoxetine share?

Both drugs carry disproportionality signals for serotonin syndrome, major depression, hyperreflexia, anorgasmia, clonus. Shared signals often reflect a shared drug class or the condition both are used for.

Is Venlafaxine or Fluoxetine safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.